Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models

References

• Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines, chap. 23. 6th ed. Philadelphia (PA): Elsevier Saunders; 2013. p. 447–492.
   Google Scholar
• Gordon JE, Hood RI. Whooping cough and its epidemiological anomalies. Am J Med Sci. 1951;222:333–361.
   PubMed Web of Science ®Google Scholar
• Shapiro-Shapin CG. Pearl Kendrick, Grace Eldering, and the pertussis vaccine. Emerg Infect Dis. 2010;16:1273–1278. doi:10.3201/eid1608.100288.
   PubMed Web of Science ®Google Scholar
• Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011;3:183–188. doi:10.1016/j.epidem.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA,  Brown KH,  Mijalski CM, Tiwari T, Weston EJ, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1–34.
   Google Scholar
• Skoff TH, Martin SW. Impact of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccinations on reported pertussis cases among those 11 to 18 years of age in an era of waning pertussis immunity: A follow-up analysis. JAMA Pediatr. 2016;170:453–458. doi:10.1001/jamapediatrics.2015.3886.
   PubMed Web of Science ®Google Scholar
• Domenech de Cellès M, Magpantay FMG, King AA, Rohani P. The impact of past vaccination coverage and immunity on pertussis resurgence. Sci Transl Med. 2018;10. doi:10.1126/scitranslmed.aao4496.
   PubMed Web of Science ®Google Scholar
• Magpantay F, Riolo M, Domenech de Cellès M, King A, Rohani P. Epidemiological consequences of imperfect vaccines for immunizing infections. SIAM J Appl Math. 2014;74(6):1810–1830. doi:10.1137/140956695.
   PubMed Web of Science ®Google Scholar
• Magpantay FMG, Domenech de Cellès M, Rohani P, King AA. Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity. Parasitology. 2016;143(7):835–849.
   PubMed Web of Science ®Google Scholar
• King AA, Nguyen D, Ionides EL. Statistical inference for partially observed Markov processes via the R package pomp. J Stat Softw. 2016;69:1–43. doi:10.18637/jss.v069.i12.
   Web of Science ®Google Scholar
• Ionides EL, Bretó C, King AA. Inference for nonlinear dynamical systems. Proc Natl Acad Sci USA. 2006;103:18438–18443. doi:10.1073/pnas.0603181103.
   PubMed Web of Science ®Google Scholar
• Ionides EL, Nguyen D, Atchadé Y, Stoev S, King AA. Inference for dynamic and latent variable models via iterated, perturbed Bayes maps. Proc Natl Acad Sci USA. 2015;112:719–724. doi:10.1073/pnas.1410597112.
   PubMed Web of Science ®Google Scholar
• Bento AI, Riolo MA, Choi YH, King AA, Rohani P. Core pertussis transmission groups in England and Wales: A tale of two eras. Vaccine. 2018;36:1160–1166. doi:10.1016/j.vaccine.2018.01.046.
   PubMed Web of Science ®Google Scholar
• Rohani P, Earn DJ, Grenfell BT. Opposite patterns of synchrony in sympatric disease metapopulations. Science. 1999;286:968–971.
   PubMed Web of Science ®Google Scholar
• Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. Princeton (NJ): Princeton University Press; 2008. http://www.loc.gov/catdir/toc/fy0805/2006939548.html.
   Google Scholar
• Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci. 2010;277:3239–3245. doi:10.1098/rspb.2010.0994.
   PubMed Web of Science ®Google Scholar
• Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010;330:982–985. doi:10.1126/science.1194134.
   PubMed Web of Science ®Google Scholar
• Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991. http://www.loc.gov/catdir/enhancements/fy0636/90014312-d.html.
   Google Scholar
• Lavine JS, Rohani P. Resolving pertussis immunity and vaccine effectiveness using incidence time series. Expert Rev Vaccines. 2012;11:1319–1329. doi:10.1586/erv.12.109.
   PubMed Web of Science ®Google Scholar
• Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci USA. 2011;108:7259–7264. doi:10.1073/pnas.1014394108.
   PubMed Web of Science ®Google Scholar
• Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect. 2014;142:672–684. doi:10.1017/S0950268814000211.
   PubMed Web of Science ®Google Scholar
• Domenech de Cellès M, Magpantay FMG, King AA, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci. 2016;283. doi:10.1098/rspb.2016.0343.
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014;111:787–792. doi:10.1073/pnas.1314688110.
   PubMed Web of Science ®Google Scholar
• Domenech de Cellès M, Riolo MA, Magpantay FMG, Rohani P, King AA. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. Proc Natl Acad Sci USA. 2014;111:E716–E717. doi:10.1073/pnas.1323795111.
   PubMed Web of Science ®Google Scholar
• Marchant CD, Loughlin AM, Lett SM, Todd CW, Wetterlow LH, Bicchieri R, Higham S, Etkind P, Silva E, Siber GR. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis. 1994;169:1297–1305. doi:10.1093/infdis/169.6.1297.
   PubMed Web of Science ®Google Scholar
• McGirr A, Fisman DN. Duration of pertussis immunity after dtap immunization: a meta-analysis. Pediatrics. 2015;135:331–343.
   PubMed Web of Science ®Google Scholar
• Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367:1012–1019. doi:10.1056/NEJMoa1200850.
   PubMed Web of Science ®Google Scholar
• McLean AR, Anderson RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect. 1988;100:419–442. doi:10.1017/S0950268800067170.
   PubMed Web of Science ®Google Scholar
• Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM, Salathé M. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015;11:e1004138. doi:10.1371/journal.pcbi.1004138.
   PubMed Web of Science ®Google Scholar
• Rohani P, Keeling MJ, Grenfell BT. The interplay between determinism and stochasticity in childhood diseases. Am Nat. 2002;159:469–481. doi:10.1086/339467.
   PubMed Web of Science ®Google Scholar
• Choi YH, Campbell H, Amirthalingam G, van Hoek AJ, Miller E. Investigating the pertussis resurgence in England and Wales, and options for future control. BMC Med. 2016;14:121. doi:10.1186/s12916-016-0665-8.
   PubMed Web of Science ®Google Scholar
• Campbell PT, McCaw JM, McIntyre P, McVernon J. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine. 2015;33:5794–5800. doi:10.1016/j.vaccine.2015.09.025.
   PubMed Web of Science ®Google Scholar
• Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Med. 2013;10:e1001540. doi:10.1371/journal.pmed.1001540.
   PubMed Web of Science ®Google Scholar